The recent downturn in biotech has battered Massachusetts’ world-renowned sector, and the political climate has only made it ...

Shares of major vaccine makers Moderna and Pfizer held steady even as U.S. health secretary Robert F. Kennedy Jr. abruptly ...

The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Trump administration vs. mRNA vaccines ...

The biotech’s mRNA vaccines were lauded by the first Trump administration but now are caught up in government changes to ...

The Trump administration has canceled $766 million awarded to Moderna to develop a vaccine against potential pandemic ...

The Food and Drug Administration (FDA) has approved Moderna’s next-generation mRNA COVID-19 vaccine mNexspike ®.

From eligibility to dosage and future rollout, here’s what you need to know about the FDA’s latest vaccine approval.

The US Department of Health and Human Services is terminating a contract with drugmaker Moderna to develop a vaccine to ...

The Food and Drug Administration has approved Moderna's new COVID-19 vaccine, days after the federal government tightened ...

Trump HHS ends nearly $1 billion in funding to Moderna for mRNA bird flu vaccines, citing safety concerns and lack of ...

The Food and Drug Administration approved Moderna's next-generation COVID-19 vaccine for adults 65 and older, the company ...